FASTEP

Mark For: FASTEP® trademark registration is intended to cover the categories of diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, tropical diseases, and sexually transmitted diseases; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of tumors, cardiac disease, and drugs; In vitro gender prediction test kit; In-vitro ovulation prediction test kit for home use; Ovulation test kits; Pregnancy test kits for home use. [all]

Status

2020-09-15 UTC
⟳ Refresh

LIVE APPLICATION Published for Opposition

Research	OneLook Acronym Finder
Serial Number	88866010
Registration Number	6230085
Mark Literal Elements	FASTEP
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2020-06-29
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Brandon James Leavitt
Attorney Docket Number	7234FL-1TBL

Timeline

IC 005. US 006 018 044 046 051 052. G & S: Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, tropical diseases, and sexually transmitted diseases; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of tumors, cardiac disease, and drugs; In vitro gender prediction test kit; In-vitro ovulation prediction test kit for home use; Ovulation test kits; Pregnancy test kits for home use